People  |  News  |

Expo

CPHI Japan

CPHI Japan

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World 2024 in Japan

read more
2400 1800 Anemocyte
Cell & Gene

Cell & Gene

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World 2024 in Rome

read more
2400 1800 Anemocyte
Advanced Therapies

Advanced Therapies

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Advanced Therapies 2024 in London

read more
2400 1800 Anemocyte
RNA Leaders Europe

RNA Leaders Europe

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to RNA Leaders Europe Congress 2024 in Basel, Switzerland.

read more
2400 1800 Anemocyte
mRNA-Based Therapeutics Summit

mRNA-Based Therapeutics Summit

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to mRNA Based Therapeutics Summint 2024 in Berlin.

read more
2400 1800 Anemocyte
ESGCT

ESGCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to European Society of Gene & Cell Therapy 2023 in Brussels

read more
1200 900 Anemocyte

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961